Bluejay Diagnostics (BJDX) Retained Earnings (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Retained Earnings of -$43.4 million for Q1 2026, down 4.62% sequentially from -$41.5 million in Q4 2025, and down 18.9% YoY from -$53.6 million in Q1 2025.
Bluejay Diagnostics (BJDX) Retained Earnings (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Retained Earnings for 7 years, with the latest figure at -$43.4 million in Q1 2026.
- Quarterly Retained Earnings fell 18.9% year-over-year to -$43.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.4 million (down 18.9% YoY) and the FY2025 annual result came in at -$41.5 million, down 19.75% from the prior year.
- Retained Earnings slipped to -$43.4 million in Q1 2026 per BJDX's latest filing, from -$41.5 million in the prior quarter.
- Over five years, Retained Earnings peaked at $28.7 million in Q1 2023 and troughed at -$43.4 million in Q1 2026.
- A 5-year average of -$22.8 million and a median of -$29.3 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 383.58% in 2022, then surged 395.45% in 2023.
- Over 5 years, Retained Earnings stood at -$17.0 million in 2022, then slumped by 58.56% to -$27.0 million in 2023, then declined by 28.64% to -$34.7 million in 2024, then fell by 19.75% to -$41.5 million in 2025, then decreased by 4.62% to -$43.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$43.4 million, -$41.5 million, and -$40.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | -45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.76 Mn |
| Mar 31, 2026 | -43.44 Mn |
| Dec 31, 2025 | -41.52 Mn |
| Sep 30, 2025 | -40.09 Mn |
| Jun 30, 2025 | -38.49 Mn |
| Mar 31, 2025 | -36.53 Mn |
| Dec 31, 2024 | -34.67 Mn |
| Sep 30, 2024 | -33.24 Mn |
| Jun 30, 2024 | -31.75 Mn |
| Mar 31, 2024 | -29.28 Mn |
| Dec 31, 2023 | -26.95 Mn |
| Sep 30, 2023 | -24.65 Mn |
| Jun 30, 2023 | -22.35 Mn |
| Mar 31, 2023 | 28.70 Mn |
| Dec 31, 2022 | -17.00 Mn |
| Sep 30, 2022 | -14.61 Mn |
| Jun 30, 2022 | 28.31 Mn |
| Mar 31, 2022 | -9.71 Mn |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 5.15 Mn |